Diane J. Kalina
President at BioCatalyst Yorkton, Inc.
Diane J. Kalina active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BioCatalyst Yorkton, Inc. | Director/Board Member | 2011-01-16 | - |
| President | 2004-12-31 | - |
Career history of Diane J. Kalina
Former positions of Diane J. Kalina
| Companies | Position | Start | End |
|---|---|---|---|
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Director/Board Member | 2003-03-31 | 2007-12-05 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Director/Board Member | - | - |
| President | - | - | |
GSK Products, Inc.
 GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Sales & Marketing | - | - |
PDC Biotech GmbH
 PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Chief Executive Officer | 2008-04-30 | - |
| Founder | 2008-04-30 | - | |
| E3 LITHIUM LIMITED | Director of Finance/CFO | - | - |
Statistics
International
| Canada | 5 |
| Austria | 2 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| President | 2 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
| Process Industries | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| E3 LITHIUM LIMITED | Process Industries |
| Private companies | 5 |
|---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
| BioCatalyst Yorkton, Inc. | |
PDC Biotech GmbH
PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Health Technology |
GSK Products, Inc.
GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Distribution Services |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Diane J. Kalina
- Experience
